MODIFICATION TO ABUSCREEN ONLINE COCAINE METABOLITE

Enzyme Immunoassay, Cocaine And Cocaine Metabolites

ROCHE DIAGNOSTIC SYSTEMS, INC.

The following data is part of a premarket notification filed by Roche Diagnostic Systems, Inc. with the FDA for Modification To Abuscreen Online Cocaine Metabolite.

Pre-market Notification Details

Device IDK983697
510k NumberK983697
Device Name:MODIFICATION TO ABUSCREEN ONLINE COCAINE METABOLITE
ClassificationEnzyme Immunoassay, Cocaine And Cocaine Metabolites
Applicant ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville,  NJ  08876 -3771
ContactRita Smith
CorrespondentRita Smith
ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville,  NJ  08876 -3771
Product CodeDIO  
CFR Regulation Number862.3250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-10-21
Decision Date1998-12-11
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.